North America Dialysis Market size exceeded USD 27.3 billion in 2020 and is expected to witness 3.6% CAGR from 2021 to 2027.

Get more details on this report - Request Free Sample PDF

The increasing prevalence of chronic conditions such as hypertension, diabetes and heart disease are few of the primary factors driving the North America dialysis market growth. For instance, according to the CDC 2019 report, around 37 million of American adults were estimated to be suffering with chronic kidney diseases i.e., one out of every seven or 15 percent of the adult population was diagnosed with kidney problems. Furthermore, in the U.S. around 786,000 people are suffering with ESKD, also known as end-stage renal disease (ESRD), with 71% on dialysis and 29% with a kidney transplant. Thus, dialysis is required for patients with renal diseases because it maintains body’s balance by eliminating waste, salt, and excess water. It also helps to lower blood pressure by maintaining a safe level of specific molecules in the blood, such as potassium, sodium, and bicarbonate.

North America Market, By Type

Haemodialysis segment will observe around 3.3% growth rate during the forecast period. The segment growth is due to rising cases of kidney failures in the region. Haemodialysis helps in cleaning impurities out of blood when kidneys can no longer function properly. Also, this process is often used to treat patients with failing kidneys to continue an active lifestyle. Moreover, in obese people or those with multiple prior abdominal surgeries, haemodialysis is preferred.

North America Market, By Product & Services  

Get more details on this report - Request Free Sample PDF

The equipment segment in the North America dialysis market accounted for over USD 1.9 billion revenue in 2020, owing to growing demand in in-center dialysis and home settings. Also, launch of portable and compact dialysis machines in the region will propel the segment growth.    

North America Market, By End-use

The in-center dialysis market dominated around 70% revenue share in 2020, due to the presence of healthcare professionals in dialysis centers. Moreover, the treatment and patient assessment are performed at the same location in in-center dialysis. Furthermore, in case of haemodialysis, patients go through a surgical procedure to create an access point for the dialysis pump in patient’s arm or leg for placing biocompatible synthetic tube.  In such scenarios, patient’s trust and satisfaction for treatment is much higher in dedicated dialysis centers.

Competitive Industry Landscape

Some of the prominent industry players include DaVita, Baxter, Medtronic, Rogosin Institute, and B. Braun and others. These companies have undertaken several business strategies including new product launches and mergers that aided them to gain a competitive position in the industry.

North America Market, By Country

U.S. dialysis market is set to register growth of more than 3.5% till 2027. Growing cases of renal diseases in the region owing to people’s sedentary lifestyle will create demand for dialysis equipment’s and dialysis centers in the country. For instance, in 2019, Fresenius Medical Care North America (FMCNA) manufactured 57.6 million dialyzers in the U.S. Also, FMCNA operates a network of approximately 4000 outpatient dialysis centers out of that more than 2500 are in the U.S. Thus, increasing manufacturing and availability of large number of dialysis units will support the market revenue. Moreover, several supportive programs launched by the U.S. government and presence of foremost companies in this country will favour the market expansion.